| pubmed-article:12610804 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12610804 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:12610804 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12610804 | lifeskim:mentions | umls-concept:C0005974 | lld:lifeskim |
| pubmed-article:12610804 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:12610804 | lifeskim:mentions | umls-concept:C0086268 | lld:lifeskim |
| pubmed-article:12610804 | lifeskim:mentions | umls-concept:C0333348 | lld:lifeskim |
| pubmed-article:12610804 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:12610804 | lifeskim:mentions | umls-concept:C0205267 | lld:lifeskim |
| pubmed-article:12610804 | lifeskim:mentions | umls-concept:C0439596 | lld:lifeskim |
| pubmed-article:12610804 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12610804 | pubmed:dateCreated | 2003-2-28 | lld:pubmed |
| pubmed-article:12610804 | pubmed:abstractText | Osteoclast activation or cartilage and bone destruction are developed in patients with rheumatoid arthritis (RA). The efficacy of etidronate with respect to osteoporosis, inhibition of bone resorption and destruction, and antiinflammation in RA was examined for 72 weeks. | lld:pubmed |
| pubmed-article:12610804 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12610804 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12610804 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12610804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12610804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12610804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12610804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12610804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12610804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12610804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12610804 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12610804 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:12610804 | pubmed:issn | 0315-162X | lld:pubmed |
| pubmed-article:12610804 | pubmed:author | pubmed-author:NagashimaMasa... | lld:pubmed |
| pubmed-article:12610804 | pubmed:author | pubmed-author:YoshinoShinic... | lld:pubmed |
| pubmed-article:12610804 | pubmed:author | pubmed-author:HasegawaJunJ | lld:pubmed |
| pubmed-article:12610804 | pubmed:author | pubmed-author:YamamotoMuneh... | lld:pubmed |
| pubmed-article:12610804 | pubmed:author | pubmed-author:NishijimaTohr... | lld:pubmed |
| pubmed-article:12610804 | pubmed:author | pubmed-author:KatsumataShin... | lld:pubmed |
| pubmed-article:12610804 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12610804 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:12610804 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12610804 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12610804 | pubmed:pagination | 474-9 | lld:pubmed |
| pubmed-article:12610804 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:meshHeading | pubmed-meshheading:12610804... | lld:pubmed |
| pubmed-article:12610804 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12610804 | pubmed:articleTitle | Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis. | lld:pubmed |
| pubmed-article:12610804 | pubmed:affiliation | Department of Joint Disease and Rheumatism, Nippon Medical School, Tokyo, Japan. | lld:pubmed |
| pubmed-article:12610804 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12610804 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12610804 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12610804 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12610804 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12610804 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12610804 | lld:pubmed |
